GINA OLIVETO: Open Payments
NPI 1407872765 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$192 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $63 · 2025 $192
Food & beverage: $192
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Tris Pharma Inc | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: CAPLYTA, Jornay PM, FANAPT, SPRAVATO, Dyanavel XR, Auvelity.
Industry payments across NE — which companies pay providers there.
